european/抗衰老

Topical photodynamic therapy (PDT) is a widely approved therapy for actinic keratoses, squamous cell carcinoma in-situ, superficial and certain thin basal cell carcinomas. Recurrence rates are typically equivalent to existing therapies, although inferior to surgery for nodular basal cell carcinoma.

In 1992 there were in Europe 54 schools of public health and six out of eight possible structures were represented. To meet future needs two types (the US style school of public health as a stand-alone academic entity and the cross-school programme in public health with formal ties to national

Over the last few years, there have been a number of important changes in how we appreciate and understand the aging face. Volume loss is now recognized as a major component of facial aging. Treatment options that replace lost volume are increasingly used for recontouring and rejuvenation of the

Currently a diverse range of injectable agents are used for noninvasive facial enhancement. Injectable poly-L-lactic acid (PLLA) is a biocompatible, biodegradable, synthetic polymer that is approved for correction of HIV-related facial lipoatrophy in Europe, Canada, and the United States. PLLA is

Repeated study of atherosclerosis epidemiology is performed in 5 European cities (Malme, Prague, Riga, Tallinn, Yalta) according to WHO recommendations 20 years after a similar study in the same regions. More frequent and more pronounced development of atherosclerosis in males of 20-39 years of age

Invasive alien species (IAS) are one of the major threats to global and local biodiversity. In forest ecosystems, the threats caused by IAS include hybridization, transmission of diseases and species competition. This review sets out to analyze the impact of alien plant species on forest

Accurate and physiologically meaningful biomarkers for human aging are key to assessing antiaging therapies. Given ethnic differences in health, diet, lifestyle, behavior, environmental exposures, and even average rate of biological aging, it stands to reason that aging clocks trained on datasets

In the past 5 years since their US introduction, there has been a rapid proliferation of light-based hair removal devices intended for home-use. In the last 2 years in Europe, sales already run into many tens of thousands of units with well-known multi-national companies entering the market. These

For prevention of osteoporosis and debilitating bone fractures, poor calcium intake has long been a major public health problem in Japan. However, few randomized controlled studies have been conducted to clarify the relationship between calcium intake and bone mineral density, and the effect of the

BACKGROUND Botulinum A toxin has been well documented as a successful treatment for hyperfunctional upper facial expression lines. Currently, there are two commercial sources for botulinum toxin--Botox and Dysport. Only Botox is currently available in the United States; however, both Botox and

BACKGROUND Hyaluronic acid fillers are frequently used for maintenance of youthful appearance of perioral and lip region. The introduction of Juvederm® Volbella™ with lidocaine and Juvederm® Volift™ with lidocaine to the European aesthetic market in 2012 increased the options of fillers to be used

Due to the fact that modern American and European women postpone childbirth until later in life, they are more likely to face the problem of ovarian insufficiency by the time they are ready to have children. So, the ability to restore the ovarian function safely is crucially important. Our study